This 2012 review examines the rapid tumor doubling time characteristic of small cell lung cancer (SCLC), with reported rates ranging from 25 to 217 days. The rapid proliferation contributes to aggressive clinical behavior and often presents with symptoms that mimic benign pulmonary conditions, such as infections, which can delay diagnosis.
